{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T22:40:15Z","timestamp":1740523215375,"version":"3.38.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Theoretical Biology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jtbi.2025.112069","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T17:30:43Z","timestamp":1739899843000},"page":"112069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Spatio-temporal model of combining ADT and chemotherapy with senolytic treatment in metastatic prostate cancer"],"prefix":"10.1016","volume":"602-603","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7851-8147","authenticated-orcid":false,"given":"Teddy","family":"Lazebnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avner","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtbi.2025.112069_b1","article-title":"Fisetin","author":"Alzheimer\u2019s Drug Discovery Foundation","year":"2018","journal-title":"Cognative Vitality"},{"key":"10.1016\/j.jtbi.2025.112069_b2","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx370.028","article-title":"Cabazitaxel followed by androgen deprivation therapy (ADT) significantly improves time to progression in patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC): A randomized, open label, phase III, multicenter trial","volume":"28","author":"Andren","year":"2017","journal-title":"Ann. Oncol."},{"year":"2024","author":"Anon","series-title":"Cabazitaxel dosage","key":"10.1016\/j.jtbi.2025.112069_b3"},{"key":"10.1016\/j.jtbi.2025.112069_b4","article-title":"Enzalutamide (oral route)","author":"Anon","year":"2024","journal-title":"Mayo Clin."},{"issue":"2","key":"10.1016\/j.jtbi.2025.112069_b5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172048","article-title":"Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapy","volume":"12","author":"Blute","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jtbi.2025.112069_b6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.rcim.2005.04.001","article-title":"Optimization of process route by genetic algorithms","volume":"22","author":"Bo","year":"2006","journal-title":"Robot. Comput.-Integr. Manuf."},{"key":"10.1016\/j.jtbi.2025.112069_b7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000088478","article-title":"VEGF as a key mediator of angiogenesis in cancer","volume":"69","author":"Carmeliet","year":"2005","journal-title":"Oncology"},{"key":"10.1016\/j.jtbi.2025.112069_b8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114765","article-title":"Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy","volume":"193","author":"Carpenter","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.jtbi.2025.112069_b9","first-page":"2752","article-title":"Hypoxia inducible factors-mediated inhibition of cancer by GM-CSF: A mathematical model","volume":"74","author":"Chen","year":"2012","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.jtbi.2025.112069_b10","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2020001797","article-title":"Lingering effects of chemotherapy on mature T-cells impair proliferation","volume":"4","author":"Das","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.jtbi.2025.112069_b11","first-page":"162","article-title":"Applying adaptive algorithms to epistatic domains","author":"Davis","year":"1985","journal-title":"Proc. Int. Jt. Conf. Artif. Intell."},{"issue":"14","key":"10.1016\/j.jtbi.2025.112069_b12","article-title":"Combination therapy in metastatic hormone-sensitive prostate cancer: is three a crowd?","volume":"29","author":"Davis","year":"2022","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.jtbi.2025.112069_b13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13046-022-02555-3","article-title":"Cellular senescence in cancer: clinical detection and prognostic implications","volume":"41","author":"Domen","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.jtbi.2025.112069_b14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/pros.22571","article-title":"Androgen deprivation induces senescence characteristics in prostate cancer cells in vitro and in vivo","volume":"73","author":"Ewald","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.jtbi.2025.112069_b15","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.593630","article-title":"Senescen cell depletion through targeting BCL-family proteins and mitochondria","author":"Fan","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jtbi.2025.112069_b16","article-title":"Modelling of chemotactic sprouting endothelial cells through an extracellular matrix","volume":"11","author":"Ferre-Torres","year":"2023","journal-title":"Front. Bioen. Biotechnol."},{"issue":"2","key":"10.1016\/j.jtbi.2025.112069_b17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263648","article-title":"Mathematical model of hormone sensitive prostate cancer treatment using leuprolide: A small step towards personalization","volume":"17","author":"Forys","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jtbi.2025.112069_b18","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s11538-017-0254-9","article-title":"The role of exosomes in pancreatic cancer microenvironment","volume":"80","author":"Friedman","year":"2018","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.jtbi.2025.112069_b19","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s40262-015-0271-5","article-title":"Clinical pharmacokinetic studies of enzalutamide","volume":"54","author":"Gibbons","year":"2015","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.jtbi.2025.112069_b20","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/pros.22674","article-title":"Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer","volume":"73","author":"Guerrero","year":"2013","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.jtbi.2025.112069_b21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153508","article-title":"Serum uPAR as biomarker in breast cancer recurrence: A mathematical model","volume":"11","author":"Hao","year":"2016","journal-title":"Plos One"},{"issue":"12","key":"10.1016\/j.jtbi.2025.112069_b22","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.181.12.8576","article-title":"IL-12 produced by dendritic cells augments CD8+T cell activation through the production of the chemokines CCL1 and CCL171","volume":"181","author":"Henry","year":"2008","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jtbi.2025.112069_b23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/scientificamerican0792-66","article-title":"Genetic algorithms","volume":"267","author":"Holland","year":"1992","journal-title":"Sci. Am."},{"key":"10.1016\/j.jtbi.2025.112069_b24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41581-022-00601-z","article-title":"Cellular senescence: the good, the bad, and the unknown","volume":"18","author":"Huang","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jtbi.2025.112069_b25","first-page":"1","article-title":"Cabazitaxel","volume":"201023","author":"JEVTANA","year":"2010","journal-title":"Cent. Drug Eval. Res."},{"issue":"1","key":"10.1016\/j.jtbi.2025.112069_b26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13578-022-00941-0","article-title":"Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer","volume":"12","author":"Kallenbach","year":"2022","journal-title":"Cell & Biosci."},{"issue":"49","key":"10.1016\/j.jtbi.2025.112069_b27","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1038\/onc.2013.206","article-title":"Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches","volume":"32","author":"Karantanos","year":"2013","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.jtbi.2025.112069_b28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2217\/fon-2021-0683","article-title":"IL-6 and IL-8 cytokines are associated with elevated prostate-specific antigen levels among patients with adenocarcinoma of the prostate at the uganda cancer institute","volume":"18","author":"Katongole","year":"2022","journal-title":"Futur. Oncol."},{"key":"10.1016\/j.jtbi.2025.112069_b29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jsbmb.2016.06.007","article-title":"Stimulation of cellular senescent processes, including secretory phenotypes and anti-oxidant responses, after androgen deprivation therapy in human prostate cancer","volume":"165","author":"Kawata","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biology"},{"key":"10.1016\/j.jtbi.2025.112069_b30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jbtep.2015.06.001","article-title":"Psychophsyiological reactivity during uncertainty and ambiguity processing in high and low worriers","volume":"50","author":"Kirschner","year":"2016","journal-title":"J. Behav. Ther. Exp. Psychiatry"},{"issue":"5","key":"10.1016\/j.jtbi.2025.112069_b31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178479","article-title":"Combination therapy of cancer with cancer vaccine and immune checkpoint inhibitors: A mathematical model","volume":"12","author":"Lai","year":"2017","journal-title":"Plos One"},{"issue":"30","key":"10.1016\/j.jtbi.2025.112069_b32","article-title":"How to schedule VEGF and PD-1 inhibitors in combination cancer therapy?","volume":"13","author":"Lai","year":"2019","journal-title":"BMC Syst. Biology"},{"issue":"21","key":"10.1016\/j.jtbi.2025.112069_b33","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1073\/pnas.1721559115","article-title":"Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors","volume":"115","author":"Lai","year":"2018","journal-title":"PNAS"},{"key":"10.1016\/j.jtbi.2025.112069_b34","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-52462-7","article-title":"Solving PDEs in python","author":"Langtangen","year":"2016"},{"issue":"3","key":"10.1016\/j.jtbi.2025.112069_b35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091844","article-title":"Mathematical modeling of interleukin-27 induction of anti-tumor T cells response","volume":"9","author":"Liao","year":"2014","journal-title":"Plos One"},{"issue":"3","key":"10.1016\/j.jtbi.2025.112069_b36","doi-asserted-by":"crossref","first-page":"FSO784","DOI":"10.2144\/fsoa-2022-0002","article-title":"Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy","volume":"8","author":"Lorenzo","year":"2022","journal-title":"Futur. Sci. OA"},{"key":"10.1016\/j.jtbi.2025.112069_b37","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/clinpract13040076","article-title":"The emerging role of senotherapy in cacner: A comprehensive review","volume":"68","author":"Malayaperumal","year":"2023","journal-title":"Clin. Pr."},{"issue":"1","key":"10.1016\/j.jtbi.2025.112069_b38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jtbi.2008.04.011","article-title":"A methodology for performing global uncertainty and sensitivity analysis in systems biology","volume":"254","author":"Marino","year":"2008","journal-title":"J. Theoret. Biol."},{"issue":"12","key":"10.1016\/j.jtbi.2025.112069_b39","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1158\/1535-7163.MCT-16-0515","article-title":"Fisetin enhances chemotherapeutic effect of cabazitaxel against human prostate cancer cells","volume":"15","author":"Mukhtar","year":"2016","journal-title":"Mol. Cancer Ther."},{"issue":"04","key":"10.1016\/j.jtbi.2025.112069_b40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2118\/37932-JPT","article-title":"Monte Carlo simulation: Its status and future","volume":"49","author":"Murtha","year":"1997","journal-title":"J. Pet. Technol."},{"issue":"11","key":"10.1016\/j.jtbi.2025.112069_b41","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.it.2023.09.003","article-title":"IL-2-driven CD8+T cell phenotypes: implications for immunotherapy","volume":"44","author":"Niederlova","year":"2023","journal-title":"Trends Immunol."},{"issue":"24","key":"10.1016\/j.jtbi.2025.112069_b42","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.3390\/cells11244026","article-title":"Therapy-induced stromal senescence promoting aggressiveness of prostate and ovarian cancer","volume":"11","author":"Pardella","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.jtbi.2025.112069_b43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3349\/ymj.2022.0244","article-title":"Effectiveness of adding docetaxel to androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in Korean real-world practice","volume":"54","author":"Park","year":"2023","journal-title":"Yonsei Med. J."},{"issue":"8","key":"10.1016\/j.jtbi.2025.112069_b44","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.3390\/app10082721","article-title":"Review: Mathematical modeling of prostate cancer and clinical application","volume":"10","author":"Phan","year":"2020","journal-title":"Appl. Sci."},{"issue":"59","key":"10.1016\/j.jtbi.2025.112069_b45","article-title":"Senolytic compounds control a distinct fate of androgen receptor agonist- and antagonist-induced cellular senescent LNCaP prostate cancer cells","volume":"10","author":"Pungsrinont","year":"2020","journal-title":"Cell Biosci."},{"issue":"3","key":"10.1016\/j.jtbi.2025.112069_b46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-0043-1772219","article-title":"Fisetin\u2019s promising antitumor effects: Uncovering mechanisms and targeting for future therapies","volume":"10","author":"Qaed","year":"2023","journal-title":"Glob. Med. Genet."},{"key":"10.1016\/j.jtbi.2025.112069_b47","article-title":"Mathematical modelling of the dynamics of prostate cancer with a curative vaccine","volume":"11","author":"Salim","year":"2021","journal-title":"Sci. Afr."},{"key":"10.1016\/j.jtbi.2025.112069_b48","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","article-title":"Senescence and cancer \u2014 role and therapeutic opportunities","volume":"19","author":"Schmitt","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jtbi.2025.112069_b49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262453","article-title":"Combination therapy for mCRPC with immune checkpoint inhibitors, ADT and vaccine: A mathematical model","volume":"17","author":"Siewe","year":"2022","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jtbi.2025.112069_b50","article-title":"Optimal timing of steroid initiation in response to CTLA-4 antibody in metastatic cancer: A mathematical model","volume":"17","author":"Slewe","year":"2022","journal-title":"Plos One"},{"issue":"8","key":"10.1016\/j.jtbi.2025.112069_b51","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa1503747","article-title":"Chemohormonal therapy in metastatic hormone-sensitive prostate cancer","volume":"373","author":"Sweeney","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtbi.2025.112069_b52","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1038\/s41598-020-59343-2","article-title":"Preferential targeting cancer-related i-motif DNAs by the plant flavonol fisetin for theranostics applications","volume":"10","author":"Takahashi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtbi.2025.112069_b53","article-title":"What is fisetin? Benefits, dosage, and risks","author":"Underwood","year":"2023","journal-title":"VitalityPro"},{"issue":"5","key":"10.1016\/j.jtbi.2025.112069_b54","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1137\/S1064827503429168","article-title":"An implicit-explicit Runge\u2013Kutta\u2013Chebyshev scheme for diffusion-reaction equations","volume":"25","author":"Verwer","year":"2004","journal-title":"SIAM J. Sci. Comput."},{"issue":"1","key":"10.1016\/j.jtbi.2025.112069_b55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2249.1999.00766.x","article-title":"Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)","volume":"115","author":"Viallard","year":"1999","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.jtbi.2025.112069_b56","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.trecan.2020.05.004","article-title":"Senescent cells in cancer therapy: Friends or foes","volume":"6","author":"Wang","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jtbi.2025.112069_b57","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082134","article-title":"Senescence and cancer: A review of clinical implications of sensescence and senotherapies","author":"Wyld","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jtbi.2025.112069_b58","article-title":"A new perspective on prostate cancer treatment: the interplay between cellular senescence and treatment resistance","volume":"15","author":"Xu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtbi.2025.112069_b59","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.759761","article-title":"The paradoxical role of cellular senescence in cancer","author":"Yang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jtbi.2025.112069_b60","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.76284","article-title":"Evolution-based mathematical models significantly prolong response to abiraterone in metastatic castrate-resistant prostate cancer and identify strategies to further improve outcomes","volume":"11","author":"Zhang","year":"2022","journal-title":"ELife"},{"key":"10.1016\/j.jtbi.2025.112069_b61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s40001-023-01271-8","article-title":"Biological effects and mechanisms of fisetin in cancer: a promising anti-cancer agent","volume":"28","author":"Zhou","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.jtbi.2025.112069_b62","doi-asserted-by":"crossref","DOI":"10.18632\/aging.101202","article-title":"New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463","volume":"9","author":"Zhu","year":"2017","journal-title":"Aging"}],"container-title":["Journal of Theoretical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519325000359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519325000359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T22:16:26Z","timestamp":1740521786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022519325000359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":62,"alternative-id":["S0022519325000359"],"URL":"https:\/\/doi.org\/10.1016\/j.jtbi.2025.112069","relation":{},"ISSN":["0022-5193"],"issn-type":[{"type":"print","value":"0022-5193"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatio-temporal model of combining ADT and chemotherapy with senolytic treatment in metastatic prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Theoretical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtbi.2025.112069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112069"}}